Substance / Medication

Pantothenic acid

Overview

Active Ingredient
niacinamide
RxNorm CUI
7405

Indications

Dialyvite 3000 is a prescription folic acid supplement with additional nutrients indicated for use in improving the nutritional status of renal dialysis patients.

Labeler: Hillestad Pharmaceuticals USAUpdated: 2027-01-27T00:00:00.000ZFull label on DailyMed

Contraindications

When this intervention should not be used

This product is contraindicated in patients with known hypersensitivity to any of the ingredients.

Indications & Related Conditions

Conditions associated via SNOMED clinical relationships

Administration & Protocol

Dosing, route, and treatment protocol

Detailed dosage and administration information is available in the full FDA drug label.

View full prescribing information on DailyMed

Monitoring & Follow-Up

Biomarkers relevant to this intervention via related conditions

Clinical Trials

20 trials linked to this intervention

20
Total Trials
0
Recruiting
10
With Results

Research Evidence

Published studies and systematic reviews

Sort:
Acute pantothenic acid and cysteine supplementation does not affect muscle coenzyme A content, fuel selection, or exercise performance in healthy humans.
Wall Benjamin T, Stephens Francis B, Marimuthu Kanagaraj et al. · J Appl Physiol (1985) · 2012
PMID: 22052867RCT
O2C Laser Doppler and Digital Photo Analysis for Treatment Evaluation of Beta-Glucan versus Provitamin Pantothenic Acid of Facial Burns.
Thieme Daniel, Spilker Gerald, Lefering Rolf et al. · Facial Plast Surg · 2016
PMID: 27097145Observational
D-pantethine has vitamin activity equivalent to d-pantothenic acids for recovering from a deficiency of D-pantothenic acid in rats.
Shibata Katsumi, Kaneko Mayu, Fukuwatari Tsutomu · J Nutr Sci Vitaminol (Tokyo) · 2013
PMID: 23727638Observational
Biotin, niacin, and pantothenic acid assay using lyophilized lactobacillus plantarum ATCC 8014.
Tsuda Harutoshi, Matsumoto Teruki, Ishimi Yoshiko · J Nutr Sci Vitaminol (Tokyo) · 2011
PMID: 22472287Observational
Pantothenic acid quantification: method comparison of a stable isotope dilution assay and a microbiological assay.
Rychlik Michael, Roth-Maier Dora · Int J Vitam Nutr Res · 2005
PMID: 16028638Observational
Long-term treatment of Barth syndrome with pantothenic acid: a retrospective study.
Rugolotto Simone, Prioli Maria D, Toniolo Daniela et al. · Mol Genet Metab · 2003
PMID: 14654353Case Report

Research data from MEDLINE/PubMed

Benefits & Expected Outcomes

Benefits, expected outcomes, efficacy data, and NNT (Number Needed to Treat) are pending physician authorship and evidence review.

Risks & Side Effects

Adverse reaction and safety data for this drug is sourced from the FDA-approved label.

View adverse reactions & drug interactions on DailyMed

Related Symptoms

Symptoms associated with conditions this intervention addresses

No related symptoms have been mapped yet. Symptom linkages are derived through associated conditions.

Alternatives & Comparisons

Alternative treatments, comparison data, and clinical decision support are pending physician authorship.

Medical Disclaimer

This information is for educational purposes only and does not constitute medical advice, diagnosis, or treatment. Always consult with a qualified healthcare provider regarding any medical condition or treatment plan.

Do not start, stop, or change any treatment without consulting your healthcare provider.

Health Goals

Goals connected through associated conditions

Quick Facts

Type
Substance / Medication
Fully Specified Name
Pantothenic acid (substance)
SNOMED CT
86431009
UMLS CUI
C0028027
RxNorm CUI
7405
Labeler
Hillestad Pharmaceuticals USA

Clinical Data

This intervention maps to 12 entities in the Healos knowledge graph.

7
Conditions
2
Biomarkers
2
Specialists
0
Symptoms
20
Clinical Trials

Data is sourced from SNOMED CT, UMLS, and the Healos clinical knowledge graph. Content sections marked as pending require physician authorship. Consult a healthcare provider before starting any treatment.